Milad Adloo, DPM
Podiatrist · New York, NYNPI 1619596269
Payments from drug & device makers
Across 53 payments — averaging $83.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$1K
- KCI USA, Inc.$1K
- Treace Medical Concepts, Inc.$700
- Stryker$387
- Johnson & Johnson$263
- Linvatec Corporation$123
- plus $294 from 7 others
What the payments were for
- Travel & lodging$2,27452%
- Food & beverage$2,12548%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 18 | $1,414 |
| KCI USA, Inc. | 8 | $1,219 |
| Treace Medical Concepts, Inc. | 7 | $700 |
| Stryker | 4 | $387 |
| Johnson & Johnson | 4 | $263 |
| Linvatec Corporation | 1 | $123 |
| Suvon Surgical LLC | 2 | $72 |
| Smith+Nephew | 3 | $66 |
| Orthofix Medical, Inc. | 2 | $40 |
| Mimedx Group, Inc. | 1 | $35 |
| Merck | 1 | $35 |
| Viiv Healthcare Company | 1 | $24 |
| Lifenet Health | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tegaderm$1,095
- PREVENA$1,095
- 3M Cavilon$995
- FISTULA SOLUTION$682
- V.A.C. VERAFLO CLEANSE CHOICE$682
- Lapiplasty System$366
- LIMFLOW SYSTEM$175
- AUGMENT INJECTABLE$170
- TMC NANOPLASTY SYSTEM$153
- BioBrace 23mm$123
- COLINK PLATING SYSTEM$123
- MOTOBAND$103
- HAMMERLOCK$103
- Cavilon$100
How this compares
$4,399 in reported general payments places this provider in the 85th percentile of 862 podiatrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 15 | $483 |
| Ammonium Lactate | 11 | $302 |
| Meloxicam | 11 | $27 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in New York
- Elvis DanneNew York$35K
- Siddhartha SharmaNew York$13K
- Neil ZwiebelNew York$12K
- Christopher BromleyPoughkeepsie$152K
- Scott GawlikBrooklyn$77K
- Waldemar MajdanskiAstoria$71K
- Michael HutzelSeaford$64K
- Donald RubinCorning$53K
- Steven NormanMiddle Village$42K
- Adam CirlincioneGlen Cove$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.